IGC Pharma, Inc.

IGC Pharma, Inc. financial statements

IGC Pharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 1.27M10-KT
Net income−USD 7.12M10-KT
Cash and equivalentsUSD 405K10-KT
Total debtUSD 137K10-KT

IGC Pharma, Inc. financials on 6ix · IGC Pharma, Inc. on 6ix